Fluconazole NDC 59762-5030

NDC codes

FDA NDC Directory

Product NDC (as listed)59762-5030Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59762-5030Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59762-5030-1	59762503001	1 BOTTLE in 1 CARTON (59762-5030-1) / 35 mL in 1 BOTTLEMarketed from Dec 23, 1993

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluconazole
Generic name (nonproprietary): fluconazole
Active ingredients: Fluconazole — 40 mg/mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Mylan Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 020090
Marketing start: Dec 23, 1993
Listing expires: Dec 31, 2027
Other FDA classes: Azoles (Chemical structure)Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 2C9 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
Identifiers: Product ID 59762-5030_5a926244-1653-4a4e-9a60-9713a91d2485SPL ID 5a926244-1653-4a4e-9a60-9713a91d2485SPL set ID 737e0fac-a2d2-4053-a0d7-edbfb6248f69RxCUI 197698, 197699, 197700, 197701, 310352, 310353UNII 8VZV102JFYUPC 0359762503015, 0359762501516, 0359762502919
Pharmacologic class: Azole Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459762503001 followed by a unit qualifier and the quantity

Package 59762-5030-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 2, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fluconazole is indicated for the treatment of: 1. Vaginal candidiasis (vaginal yeast infections due to Candida ). 2. Oropharyngeal and esophageal candidiasis. In open noncomparative studies of relatively small numbers of patients, fluconazole was also effective for the treatment of Candida urinary tract infections, peritonitis, and systemic Candida infections including candidemia, disseminated candidiasis, and pneumonia. 3. Cryptococcal meningitis. Before prescribing fluconazole for AIDS patients with cryptococcal meningitis, please see CLINICAL STUDIES section. Studies comparing fluconazole to amphotericin B in non-HIV infected patients have not been conducted. Specime…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020090

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020090
Product	Strength	Form · route	Labeler	Product NDC
Diflucanfluconazole	Fluconazole 1400 mg/35mL	Powder, For suspensionOral	Roerig	0049-3450
Fluconazole	Fluconazole 10 mg/mL	Powder, For suspensionOral	Mylan Pharmaceuticals Inc.	59762-5029